HomeGLUE • NASDAQ
add
Monte Rosa Therapeutics Inc
Previous close
$5.09
Day range
$5.00 - $5.19
Year range
$2.44 - $8.84
Market cap
311.16M USD
Avg Volume
342.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 4.70M | — |
Operating expense | 37.34M | 0.31% |
Net income | -30.31M | 13.84% |
Net profit margin | -645.58 | — |
Earnings per share | -0.43 | 39.44% |
EBITDA | -30.58M | 14.65% |
Effective tax rate | -0.84% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 262.20M | 29.12% |
Total assets | 344.11M | 23.51% |
Total liabilities | 119.44M | 83.87% |
Total equity | 224.67M | — |
Shares outstanding | 61.37M | — |
Price to book | 1.39 | — |
Return on assets | -26.72% | — |
Return on capital | -34.97% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -30.31M | 13.84% |
Cash from operations | -27.77M | -9.65% |
Cash from investing | -61.16M | -429.69% |
Cash from financing | 98.02M | 8,068.58% |
Net change in cash | 9.10M | 263.22% |
Free cash flow | -28.78M | -14.65% |
About
Founded
2019
Headquarters
Website
Employees
129
